BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22039701)

  • 1. [Mathematical modeling of low-grade glioma].
    Mandonnet E
    Bull Acad Natl Med; 2011 Jan; 195(1):23-34; discussion 34-6. PubMed ID: 22039701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modeling of glioma on MRI.
    Mandonnet E
    Rev Neurol (Paris); 2011 Oct; 167(10):715-20. PubMed ID: 21890155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of cerebral glioma with advanced magnetic resonance techniques].
    Graça J; Palma T; Pereira P; Medina P; Ribeiro C; Evangelista P
    Acta Med Port; 2003; 16(3):117-23. PubMed ID: 12868389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using mathematical modeling to predict survival of low-grade gliomas.
    Alvord EC; Swanson KR
    Ann Neurol; 2007 May; 61(5):496; author reply 496-7. PubMed ID: 17252546
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-grade glioma: current management and controversies.
    Bauman G; Shaw EG
    Clin Adv Hematol Oncol; 2003 Sep; 1(9):546-53. PubMed ID: 16258447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth analysis and evaluation of diffusive glioma models.
    Roniotis A; Sakkalis V; Karatzanis I; Zervakis ME; Marias K
    IEEE Trans Inf Technol Biomed; 2012 May; 16(3):299-307. PubMed ID: 22287245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain glioma growth model using reaction-diffusion equation with viscous stress tensor on brain MR images.
    Yuan J; Liu L
    Magn Reson Imaging; 2016 Feb; 34(2):114-9. PubMed ID: 26518060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multivariate analysis of the prognostic factors of grade III gliomas.
    Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
    Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
    Kim B; Chenevert TL; Ross BD
    Clin Cancer Res; 1995 Jun; 1(6):643-50. PubMed ID: 9816027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
    Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
    Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of mathematical modeling of glioma proliferation and invasion.
    Harpold HL; Alvord EC; Swanson KR
    J Neuropathol Exp Neurol; 2007 Jan; 66(1):1-9. PubMed ID: 17204931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous growth of mean tumor diameter in a subset of grade II gliomas.
    Mandonnet E; Delattre JY; Tanguy ML; Swanson KR; Carpentier AF; Duffau H; Cornu P; Van Effenterre R; Alvord EC; Capelle L
    Ann Neurol; 2003 Apr; 53(4):524-8. PubMed ID: 12666121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic glioma characterization from dynamic susceptibility contrast imaging: brain tumor segmentation using knowledge-based fuzzy clustering.
    Emblem KE; Nedregaard B; Hald JK; Nome T; Due-Tonnessen P; Bjornerud A
    J Magn Reson Imaging; 2009 Jul; 30(1):1-10. PubMed ID: 19557840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma?
    Lam WW; Poon WS; Metreweli C
    Clin Radiol; 2002 Mar; 57(3):219-25. PubMed ID: 11952318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-specific characterization of the invasiveness and proliferation of low-grade gliomas using serial MR imaging and a mathematical model of tumor growth.
    Hathout L; Ellingson BM; Cloughesy TF; Pope WB
    Oncol Rep; 2015 Jun; 33(6):2883-8. PubMed ID: 25962999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates.
    Pallud J; Taillandier L; Capelle L; Fontaine D; Peyre M; Ducray F; Duffau H; Mandonnet E
    Neurosurgery; 2012 Sep; 71(3):729-39; discussion 739-40. PubMed ID: 22668885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity.
    Lee HY; Na DG; Song IC; Lee DH; Seo HS; Kim JH; Chang KH
    J Comput Assist Tomogr; 2008; 32(2):298-303. PubMed ID: 18379322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modeling of the malignancy of cancer using graph evolution.
    Gunduz-Demir C
    Math Biosci; 2007 Oct; 209(2):514-27. PubMed ID: 17462676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk of increased malignancy a reason for follow-up of low malignancy grade glioma. Early identification of high-risk patients is the key to good care].
    Smits A; Ribom D
    Lakartidningen; 2000 Sep; 97(36):3886-90. PubMed ID: 11036339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.